Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.

Medical mycology - 1 Oct 2020

Silva Vanessa K A, May Robin C, Rodrigues Marcio L

Abstract excerpt

Cryptococcosis is a life-threatening fungal infection. New therapeutic approaches are necessary to combat cryptococcosis, as the currently available therapeutic protocols are expensive and generally result in deleterious side effects. Pyrifenox is an antifungal compound that affects phytopathogens by inhibiting the biosynthesis of ergosterol. In this study, we investigated the effects of pyrifenox on Cryptococcus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Cryptococcosis
Share to Cryptococcus gattii

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cryptococcus neoformans

Share to Ergosterol

Share to Macrophages

Share to Oximes

Share to Pyridines

Source

Identifiers

PMID: 31915833
DOI: 10.1093/mmy/myz132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.PMID 31915833Read ↗

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.Semantic proximity Read ↗

The emerging fungal pathogen Cryptococcus gattii: Epidemiology, pathogenesis, immunomodulatory attributes, and drug susceptibilitySemantic proximity Read ↗

Comparison of Cryptococcus gattii/neoformans Species Complex to Related Genera (Papiliotrema and Naganishia) Reveal Variances in Virulence Associated Factors and Antifungal SusceptibilitySemantic proximity Read ↗

Peeling the onion: the outer layers of Cryptococcus neoformansSemantic proximity Read ↗

Faster Cryptococcus Melanization Increases Virulence in Experimental and Human CryptococcosisSemantic proximity Read ↗

Brilacidin, a novel antifungal agent against <i>Cryptococcus neoformans</i>Semantic proximity Read ↗

Faster <i>Cryptococcus</i> melanization increases virulence in experimental and human cryptococcosisSemantic proximity Read ↗

Hinokitiol alters Gene Expression in <i>Aspergillus fumigatus</i> , protects against fungal keratitis by Reducing Fungal Load, LOX-1, Proinflammatory cytokines and Neutrophil InfiltrationSemantic proximity Read ↗

Cryptococcosis caused by cryptococcus gattii: 2 case reports and literature review.Semantic proximity Read ↗

Role of glucuronoxylomannan and steryl glucosides in protecting against cryptococcosis.Semantic proximity Read ↗

Strain-specific variation in virulence and host-immune modulation across the Cryptococcus gattii species complex.Semantic proximity Read ↗

Virulence Factors as Targets for Anticryptococcal TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.